What are the opening hours?

Monday 7am - 3pm Tuesday 7am - 3pm Wednesday 7am - 3pm Thursday 7am - 3pm Friday 7am - 3pm

XPRT ANALYTICAL SERVICES Corporation, 3759 Skrene Properties Bldg. , Cuenca cor. Emilia Street , Palanan, Makati City, Makati (2026)

Q: What is the address?

3759 Skrene Properties Bldg. , Cuenca Cor. Emilia Street , Palanan, Makati City

23/10/2026

𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲! 🎉

𝐍𝐢𝐭𝒂𝐳𝐨𝐱𝒂𝐧𝐢𝐝𝐞 is a broad-spectrum oral antiparasitic medication primarily prescribed to treat intestinal infections caused by single-celled protozoa, such as 𝑮𝒊𝒂𝒓𝒅𝒊𝒂 𝒍𝒂𝒎𝒃𝒍𝒊𝒂 and 𝑪𝒓𝒚𝒑𝒕𝒐𝒔𝒑𝒐𝒓𝒊𝒅𝒊𝒖𝒎 𝒑𝒂𝒓𝒗𝒖𝒎. These microscopic parasites are frequently transmitted through contaminated water and food, causing gastrointestinal conditions such as traveler's diarrhea. Nitazoxanide helps inhibit these harmful parasites, relieving distressing symptoms such as severe diarrhea, stomach pain, and abdominal cramps.

Rather than acting as a traditional antibiotic, nitazoxanide targets specific metabolic pathways crucial to the survival of anaerobic organisms. Upon administration, it works by shutting down the parasite's internal energy production, stopping its growth and allowing the body's immune system to safely flush the infection out. Nitazoxanide is approved for use in both adults and pediatric patients aged 1 year and older.

𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦 𝐨𝐟 𝐀𝐜𝐭𝐢𝐨𝐧
𝐀𝐜𝐭𝐢𝐯𝐚𝐭𝐢𝐨𝐧: Once ingested, nitazoxanide is rapidly metabolized in the body into its active metabolite, 𝒕𝒊𝒛𝒐𝒙𝒂𝒏𝒊𝒅𝒆.

𝑬𝒏𝒛𝒚𝒎𝒆 𝑩𝒍𝒐𝒄𝒌: It blocks the 𝒑𝒚𝒓𝒖𝒗𝒂𝒕𝒆:𝒇𝒆𝒓𝒓𝒆𝒅𝒐𝒙𝒊𝒏 𝒐𝒙𝒊𝒅𝒐𝒓𝒆𝒅𝒖𝒄𝒕𝒂𝒔𝒆 (𝑷𝑭𝑶𝑹) enzyme-dependent electron transfer reaction, shutting down essential anaerobic energy metabolism in the parasite.

𝑬𝒍𝒊𝒎𝒊𝒏𝒂𝒕𝒊𝒐𝒏: Deprived of cellular energy, growth of 𝑮𝒊𝒂𝒓𝒅𝒊𝒂 and 𝑪𝒓𝒚𝒑𝒕𝒐𝒔𝒑𝒐𝒓𝒊𝒅𝒊𝒖𝒎 is inhibited, allowing the host immune system to successfully clear the infection.

𝐂𝐨𝐦𝐦𝐨𝐧 𝐒𝐢𝐝𝐞 𝐄𝐟𝐟𝐞𝐜𝐭𝐬
Common side effects of nitazoxanide are generally mild and may include abdominal pain, nausea, headache, and temporary, harmless urine discoloration.

𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭
Nitazoxanide should be taken with food to maximize absorption. Always complete the full course of treatment as prescribed by a medical professional.

✨ A Moment of Reflection ✨
🌿 "For I will restore health to you, and your wounds I will heal, declares the Lord." — Jeremiah 30:17

𝐑𝐄𝐅𝐄𝐑𝐄𝐍𝐂𝐄𝐒
[1] DrugBank. Nitazoxanide profile (DB00507). https://go.drugbank.com/drugs/DB00507

[2] Drugs.com. Nitazoxanide medical information & side effects. https://www.drugs.com/mtm/nitazoxanide.html

[3] Medicine.com. Nitazoxanide prescribing & HCP guide. https://www.medicine.com/drug/nitazoxanide/hcp

[4] National Center for Biotechnology Information. PubChem Compound Summary for CID 41684, Nitazoxanide. https://pubchem.ncbi.nlm.nih.gov/compound/Nitazoxanide

XPRT Analytical Services Corporation is one of the leading analytical laboratory services companies providing advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

20/10/2026

𝐓𝐫𝐢𝐯𝐢𝐚 𝐓𝐮𝐞𝐬𝐝𝐚𝐲! 💊

𝑻𝒂𝒇𝒍𝒖𝒑𝒓𝒐𝒔𝒕 is a prostaglandin analogue used to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It works by mimicking the effects of prostaglandin F2α-related compounds and activating prostanoid receptors in the eye, which increases the outflow of aqueous humor through the uveoscleral pathway. Aqueous humor is the clear fluid that nourishes the eye and maintains its shape. By improving fluid drainage, tafluprost helps prevent excessive pressure buildup that can damage the optic nerve and lead to progressive vision loss.

After administration, tafluprost is converted into its active metabolite, tafluprost acid, which produces its pressure-lowering effect. It is commonly administered as eye drops once daily in the evening, as prescribed by a healthcare professional. Regular use and eye examinations are important to monitor treatment effectiveness and potential side effects, such as eye redness, eyelash growth, and gradual darkening of iris pigmentation.

𝗠𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝗺 𝗼𝗳 𝗔𝗰𝘁𝗶𝗼𝗻 💊
Tafluprost is a fluorinated analogue of prostaglandin F2α (PGF2α) and a potent, selective agonist of the FP prostanoid receptor. It is used as an ophthalmic medication to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Tafluprost acts as a prodrug, meaning it is converted into its biologically active metabolite, tafluprost acid, after penetrating the cornea. This active metabolite stimulates FP receptors in the eye, promoting the outflow of aqueous humor through the uveoscleral pathway. Aqueous humor is the clear fluid that nourishes the eye and helps maintain its internal pressure. By increasing fluid drainage, tafluprost helps lower IOP and reduce the risk of optic nerve damage associated with glaucoma. Although its pressure-lowering effect is established, the exact cellular mechanism responsible for increasing uveoscleral outflow has not been fully elucidated.

𝗖𝗼𝗺𝗺𝗼𝗻 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁𝘀
Tafluprost eye drops may cause several side effects, particularly involving the eyes. Eye redness (conjunctival 𝒉𝒚𝒑𝒆𝒓𝒆𝒎𝒊𝒂) is one of the most commonly reported effects and occurs when blood vessels on the eye's surface become more visible. Other possible effects include cataract formation, blurred vision, and headache. Some patients may also experience respiratory symptoms, such as a stuffy nose, cough, or sore throat, as well as a urinary tract infection (UTI). In clinical studies, headache, cough, common cold, and UTI were reported in some patients using tafluprost, although these effects do not necessarily occur in everyone or prove that the medication caused them. Patients should consult a healthcare professional if side effects persist or worsen, and seek prompt medical attention for sudden vision changes, significant eye pain, or swelling.

𝗣𝗿𝗲𝗰𝗮𝘂𝘁𝗶𝗼𝗻𝘀 ⚠
Regular visits to an ophthalmologist are essential while using tafluprost to monitor treatment effectiveness and identify possible adverse effects. The medication may gradually cause increased iris pigmentation, making the treated eye appear darker over several months or years. It may also cause eyelashes to become longer, thicker, or more prominent, with these changes generally limited to the treated eye and potentially reversible after discontinuation. Additionally, symptoms such as itching, redness, swelling, or irritation of the eyes or eyelids may indicate an allergic reaction and should be reported to a healthcare professional. Patients should consult their ophthalmologist if they notice unusual changes or have concerns during treatment.

𝗥𝗘𝗙𝗘𝗥𝗘𝗡𝗖𝗘𝗦
Mayo Clinic. (n.d.). Tafluprost (ophthalmic route). https://www.mayoclinic.org/drugs-supplements/tafluprost-ophthalmic-route/description/drg-20075545

National Center for Biotechnology Information (2026). PubChem Compound Summary for CID 125463293, Tafluprost Impurity 6. Retrieved October 17, 2026 from Chemical Structure. https://pubchem.ncbi.nlm.nih.gov/compound/Tafluprost-Impurity-6

Ohashi, M., & colleagues. (2010). Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension. Clinical Ophthalmology, 4, 163–170. https://pmc.ncbi.nlm.nih.gov/articles/PMC2850830/

U.S. National Library of Medicine. (2026). Tafluprost ophthalmic solution: Drug label information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcaab8b3-3791-49ba-909e-a09651a30b33

U.S. National Library of Medicine. (n.d.). Tafluprost ophthalmic solution: Prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bfffa484-4105-45ec-ab1d-124e96639f35

U.S. National Library of Medicine. (n.d.). Tafluprost ophthalmic. MedlinePlus. https://medlineplus.gov/druginfo/meds/a612030.html

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

16/10/2026

𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲!🎉

𝐕𝐢𝐥𝐨𝐱𝐚𝐳𝐢𝐧𝐞 is a prescription medication classified as a selective norepinephrine reuptake inhibitor (NRI). It is available in an extended-release oral formulation and is approved for the treatment of ADHD in children aged 6 years and older, adolescents, and adults. It is intended to help manage symptoms that may affect attention, behavior, and everyday activities.

𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦 𝐨𝐟 𝐀𝐜𝐭𝐢𝐨𝐧
Viloxazine primarily inhibits the reuptake of norepinephrine, a neurotransmitter that plays an important role in attention, alertness, and impulse control. It may also influence serotonin signaling in the brain. However, its exact mechanism of action in treating ADHD is not yet fully understood.

Norepinephrine helps regulate communication between nerve cells and supports brain functions involved in concentration and behavioral control. By affecting norepinephrine and serotonin signaling, viloxazine may influence neural processes associated with ADHD symptoms. Further research is still needed to fully understand how these effects contribute to its therapeutic benefits.

𝐇𝐨𝐰 𝐈𝐭 𝐖𝐨𝐫𝐤𝐬
By increasing the availability of norepinephrine in the brain, viloxazine may help regulate processes associated with attention, alertness, and behavioral control. Norepinephrine plays an important role in brain functions related to concentration and impulse regulation, which are often affected in individuals with ADHD. Through its effects on neurotransmitter signaling, viloxazine may help improve focus, manage impulsive behaviors, and support daily functioning. However, its exact therapeutic mechanism in ADHD is not yet fully understood, and treatment responses may vary from person to person. Regular follow-up with a healthcare professional is important to monitor treatment effectiveness, side effects, and overall progress.

𝐂𝐨𝐦𝐦𝐨𝐧 𝐒𝐢𝐝𝐞 𝐄𝐟𝐟𝐞𝐜𝐭𝐬
Common side effects of viloxazine include decreased appetite, nausea, vomiting, stomach pain, fatigue, drowsiness, irritability, and insomnia or difficulty sleeping. Not everyone experiences these effects, and their severity may differ from person to person. Consult a healthcare professional if side effects persist, worsen, or interfere with daily activities.

𝐒𝐚𝐟𝐞𝐭𝐲 𝐑𝐞𝐦𝐢𝐧𝐝𝐞𝐫⚠
Viloxazine should be taken only as prescribed by a qualified healthcare professional, and patients should follow the recommended dosage instructions carefully. Inform your healthcare provider about other medications or supplements you are taking to help prevent potentially harmful drug interactions. Patients and caregivers should also monitor for unusual mood or behavioral changes, including suicidal thoughts or behaviors, and seek immediate medical assistance if these occur.

Reference:
[1] Haddad, H. W., Hankey, P. B., Ko, J., Eswani, Z., Bhatti, P., Edinoff, A. N., Kaye, A. M., & Kaye, A. D. (2022). Viloxazine, a non-stimulant norepinephrine reuptake inhibitor, for the treatment of attention deficit hyperactivity disorder: A 3 year update. Health Psychology Research, 10(3), 37018. https://doi.org/10.52965/001c.37018

[2] Viloxazine. (n.d.). Go.Drugbank.Com. Retrieved October 15, 2026, from https://go.drugbank.com/drugs/DB09185

[3] Viloxazine (oral route) description and brand names - mayo clinic. (n.d.). Www.Mayoclinic.Org. Retrieved October 15, 2026, from https://www.mayoclinic.org/drugs-supplements/viloxazine-oral-route/description/drg-20512960

[4] Viloxazine oral extended-release capsules. (2023, September 20). Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/23842-viloxazine-extended-release-capsules

Image from:
[5] National Center for Biotechnology Information (2026). PubChem Compound Summary for CID 5666, Viloxazine. Retrieved October 14, 2026 from https://pubchem.ncbi.nlm.nih.gov/compound/Viloxazine

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

13/10/2026

𝐓𝐫𝐢𝐯𝐢𝐚 𝐓𝐮𝐞𝐬𝐝𝐚𝐲!🎉

𝐒𝐚𝐩𝐫𝐨𝐩𝐭𝐞𝐫𝐢𝐧 is a prescription medication and a synthetic form of 𝒕𝒆𝒕𝒓𝒂𝒉𝒚𝒅𝒓𝒐𝒃𝒊𝒐𝒑𝒕𝒆𝒓𝒊𝒏 (𝑩𝑯𝟒), a substance that occurs naturally in the body. It acts as a specialized helper molecule to support enzyme function, helping lower blood levels of 𝒑𝒉𝒆𝒏𝒚𝒍𝒂𝒍𝒂𝒏𝒊𝒏𝒆 in individuals with 𝒑𝒉𝒆𝒏𝒚𝒍𝒌𝒆𝒕𝒐𝒏𝒖𝒓𝒊𝒂 (𝑷𝑲𝑼). Rather than targeting genetic material or altering DNA, sapropterin operates directly at the protein level by binding to and stabilizing the body's natural 𝒑𝒉𝒆𝒏𝒚𝒍𝒂𝒍𝒂𝒏𝒊𝒏𝒆 𝒉𝒚𝒅𝒓𝒐𝒙𝒚𝒍𝒂𝒔𝒆 (𝑷𝑨𝑯) enzyme.

Through this stabilization, sapropterin restores enzymatic capacity, allowing excess phenylalanine to be safely converted into 𝒕𝒚𝒓𝒐𝒔𝒊𝒏𝒆 an essential compound for overall health and neurotransmitter production. By keeping phenylalanine buildup in check, it helps protect vital organs, particularly the brain, from severe neurological damage. Sapropterin is a key therapeutic option in metabolic health, bridging dietary management with targeted biochemical enzyme support.

𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦 𝐨𝐟 𝐀𝐜𝐭𝐢𝐨𝐧
𝐒𝐚𝐩𝐫𝐨𝐩𝐭𝐞𝐫𝐢𝐧 acts as an essential 𝒄𝒐𝒇𝒂𝒄𝒕𝒐𝒓 𝒌𝒆𝒚 that binds directly to the active site of deficient or unstable 𝒑𝒉𝒆𝒏𝒚𝒍𝒂𝒍𝒂𝒏𝒊𝒏𝒆 𝒉𝒚𝒅𝒓𝒐𝒙𝒚𝒍𝒂𝒔𝒆 (𝑷𝑨𝑯) enzymes. By stabilizing the enzyme's molecular structure, it prevents premature protein breakdown and boosts catalytic activity. This enables the efficient breakdown of excess dietary 𝒑𝒉𝒆𝒏𝒚𝒍𝒂𝒍𝒂𝒏𝒊𝒏𝒆 into 𝒕𝒚𝒓𝒐𝒔𝒊𝒏𝒆, preventing toxic accumulation in the bloodstream.

𝐂𝐨𝐦𝐦𝐨𝐧 𝐒𝐢𝐝𝐞 𝐄𝐟𝐟𝐞𝐜𝐭𝐬
Common side effects of sapropterin may include headache, runny or stuffy nose, sore throat, diarrhea, and vomiting. Upper respiratory tract infections and spinal pain may also occur in some patients.

𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭‼️
𝐒𝐚𝐩𝐫𝐨𝐩𝐭𝐞𝐫𝐢𝐧 requires ongoing monitoring of blood phenylalanine levels to ensure clinical effectiveness and prevent abnormally low levels (hypophenylalaninemia). Patients taking sapropterin must continue following a medically supervised, phenylalanine-restricted diet as prescribed by their healthcare provider.

𝐑𝐄𝐅𝐄𝐑𝐄𝐍𝐂𝐄𝐒
[1] Biology Insights. What is Sapropterin and How is it Used for PKU? https://biologyinsights.com/what-is-sapropterin-and-how-is-it-used-for-pku/

[2] DrugBank. Sapropterin profile (DB00360). https://go.drugbank.com/drugs/DB00360

[3] Drugs.com. Sapropterin medical information. https://www.drugs.com/mtm/sapropterin.html

[4] Mayo Clinic. Sapropterin (oral route) side effects. https://www.mayoclinic.org/drugs-supplements/sapropterin-oral-route/description/drg-20071379

[5] Medicine.com. Sapropterin prescribing & HCP guide. https://www.medicine.com/drug/sapropterin/hcp

[6] National Center for Biotechnology Information. (2026). PubChem Compound Summary for CID 135398654, Sapropterin (Including 3-D Structure & Enzyme Function Visual Models). Retrieved October 12, 2026, from https://pubchem.ncbi.nlm.nih.gov/compound/Sapropterin

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

10/10/2026

𝐗𝐏𝐑𝐓 𝐀𝐍𝐀𝐋𝐘𝐓𝐈𝐂𝐀𝐋 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧 joins the global community in observing World Mental Health Day October 10, 2026, promoting greater awareness of mental health, challenging stigma, and encouraging access to compassionate and inclusive mental health support. This year, we highlight the importance of listening to people’s lived experiences and recognizing their voices as an essential part of improving mental health care and support.

𝐌𝐞𝐧𝐭𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡 is an important component of overall well-being. Despite this, many individuals continue to experience stigma, discrimination, and difficulties in accessing appropriate mental health services. The 𝐖𝐨𝐫𝐥𝐝 𝐇𝐞𝐚𝐥𝐭𝐡 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧 (WHO) emphasizes that people who have personally experienced mental health challenges have unique insights that can help improve mental health systems. Listening to their experiences can help communities and organizations better understand people's needs and develop services that are more supportive, accessible, and responsive.

The 2026 theme, “𝑳𝒊𝒗𝒆𝒅 𝒆𝒙𝒑𝒆𝒓𝒊𝒆𝒏𝒄𝒆𝒔 𝒉𝒆𝒂𝒓𝒅: 𝒓𝒆𝒂𝒍 𝒗𝒐𝒊𝒄𝒆𝒔, 𝒓𝒆𝒂𝒍 𝒄𝒉𝒂𝒏𝒈𝒆, reminds us that people with lived experience should have a meaningful role in shaping mental health programs, policies, and services. Their stories should not only be heard but also valued and considered when making decisions that affect mental health care. By involving people with lived experience, we can help build mental health systems that are more understanding, inclusive, and centered on the needs of individuals.

𝐋𝐞𝐭’𝐬 𝐥𝐢𝐬𝐭𝐞𝐧. 𝐋𝐞𝐭’𝐬 𝐮𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝. 𝐋𝐞𝐭’𝐬 𝐜𝐫𝐞𝐚𝐭𝐞 𝐦𝐞𝐚𝐧𝐢𝐧𝐠𝐟𝐮𝐥 𝐜𝐡𝐚𝐧𝐠𝐞.
Together, we can foster a community where everyone feels comfortable sharing their experiences and seeking support without fear of judgment. By showing empathy, reducing stigma, and valuing lived experiences, we can contribute to a healthier and more supportive environment for everyone.

“𝑬𝒗𝒆𝒓𝒚 𝒗𝒐𝒊𝒄𝒆 𝒅𝒆𝒔𝒆𝒓𝒗𝒆𝒔 𝒕𝒐 𝒃𝒆 𝒉𝒆𝒂𝒓𝒅. 𝑬𝒗𝒆𝒓𝒚 𝒆𝒙𝒑𝒆𝒓𝒊𝒆𝒏𝒄𝒆 𝒉𝒂𝒔 𝒗𝒂𝒍𝒖𝒆. 𝑬𝒗𝒆𝒓𝒚 𝒂𝒄𝒕𝒊𝒐𝒏 𝒄𝒂𝒏 𝒎𝒂𝒌𝒆 𝒂 𝒅𝒊𝒇𝒇𝒆𝒓𝒆𝒏𝒄𝒆.”

For mental health concerns, do not hesitate to seek help from a trusted person or qualified mental health professional. Asking for help is a sign of strength, and no one should have to face their struggles alone.

𝐑𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞𝐬:
World Health Organization. (2026, October 10). World Mental Health Day 2026: Lived experiences heard: Real voices, real change. WHO – World Mental Health Day 2026
World Health Organization. (n.d.). World Mental Health Day. WHO – World Mental Health Day
World Health Organization. (n.d.). Mental health. WHO – Mental Health

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater to the cosmetic, veterinary, and other industries alike.

If you need more information about our services or have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

09/10/2026

𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲! 💊

𝐙𝐢𝐩𝐫𝐚𝐬𝐢𝐝𝐨𝐧𝐞 is an atypical antipsychotic medication primarily used in the treatment of 𝒔𝒄𝒉𝒊𝒛𝒐𝒑𝒉𝒓𝒆𝒏𝒊𝒂 and 𝒃𝒊𝒑𝒐𝒍𝒂𝒓 𝒅𝒊𝒔𝒐𝒓𝒅𝒆𝒓. It belongs to a class of second-generation antipsychotic drugs that act on neurotransmitter systems involved in mood, behavior, and perception. 𝐙𝐢𝐩𝐫𝐚𝐬𝐢𝐝𝐨𝐧𝐞 produces its therapeutic effects mainly by interacting with dopamine and serotonin receptors in the brain, particularly by blocking dopamine D₂ and serotonin 5-HT₂ receptors. Through these actions, it helps reduce symptoms such as hallucinations, delusions, agitation, and disorganized thinking, while also helping manage manic or mixed episodes associated with bipolar disorder.

𝐙𝐢𝐩𝐫𝐚𝐬𝐢𝐝𝐨𝐧𝐞 is available in oral formulations and is also available as an intramuscular preparation for the short-term treatment of acute agitation associated with schizophrenia. Like other antipsychotic medications, its use requires appropriate medical supervision because it may cause adverse effects and has important safety considerations, including its potential to prolong the QT interval of the heart. Overall, ziprasidone is an important medication in psychiatric treatment because of its ability to manage psychotic and mood-related symptoms through its effects on multiple neurotransmitter receptors.

𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦 𝐨𝐟 𝐀𝐜𝐭𝐢𝐨𝐧 💊
𝐙𝐢𝐩𝐫𝐚𝐬𝐢𝐝𝐨𝐧𝐞 is an atypical antipsychotic that primarily blocks 𝒅𝒐𝒑𝒂𝒎𝒊𝒏𝒆 𝑫₂ and 𝒔𝒆𝒓𝒐𝒕𝒐𝒏𝒊𝒏 𝟓-𝑯𝑻₂𝑨 𝒓𝒆𝒄𝒆𝒑𝒕𝒐𝒓𝒔, while also interacting with 𝟓-𝑯𝑻₁𝑨, 𝟓-𝑯𝑻₁𝑫, 𝒂𝒏𝒅 𝟓-𝑯𝑻₂𝑪 𝒓𝒆𝒄𝒆𝒑𝒕𝒐𝒓𝒔. Its distinctive serotonin dopamine activity contributes to its therapeutic effects on psychotic and mood symptoms. Compared with some other atypical antipsychotics, ziprasidone has a relatively favorable weight and metabolic profile, with lower affinity for histamine H₁ and muscarinic M₁ receptors. However, it can prolong the QT interval, making cardiac safety an important consideration.

𝐂𝐨𝐦𝐦𝐨𝐧 𝐒𝐢𝐝𝐞 𝐄𝐟𝐟𝐞𝐜𝐭𝐬 💊
Common side effects of ziprasidone may include drowsiness or sedation, nausea or upset stomach, dizziness, restlessness or agitation, and mild tremors or muscle stiffness. Ziprasidone can also cause QT interval prolongation, a heart rhythm abnormality that may require medical monitoring, especially in patients with cardiac risk factors.

𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭‼️
𝐙𝐢𝐩𝐫𝐚𝐬𝐢𝐝𝐨𝐧𝐞 carries a black box warning for increased mortality in elderly patients with dementia-related psychosis. It can also cause OT prolongation, a potentially serious heart rhythm issue-patients with a history of cardiac conditions should be monitored closely. It must be taken with food (at least 500 calories) for proper absorption.

🎗𝐏𝐫𝐨 𝐓𝐢𝐩:
Always take 𝐙𝐢𝐩𝐫𝐚𝐬𝐢𝐝𝐨𝐧𝐞 with a full meal-this dramatically increases its effectiveness. Be consistent with your dosing time to avoid mood fluctuations. Don't stop abruptly unless directed by your provider, as it may lead to symptom relapse.

𝐑𝐄𝐅𝐄𝐑𝐄𝐍𝐂𝐄𝐒
DrugBank. (2026). Ziprasidone: Uses, interactions, mechanism of action

Greenberg, W. M., & Citrome, L. (2007). Ziprasidone for Schizophrenia and Bipolar Disorder: A review of the clinical trials. CNS Drug Reviews, 13(2), 137–177. https://doi.org/10.1111/j.1527-3458.2007.00008.x

National Library of Medicine. (2025). Ziprasidone: MedlinePlus drug information. MedlinePlus. MedlinePlus: Ziprasidone

Stip, E., Zhornitsky, S., Moteshafi, H., Létourneau, G., Stikarovska, I., Potvin, S., & Tourjman, V. (2011). Ziprasidone for Psychotic Disorders: A Meta-Analysis and Systematic Review of the Relationship between Pharmacokinetics, Pharmacodynamics, and Clinical Profile. Clinical Therapeutics, 33(12), 1853–1867. https://doi.org/10.1016/j.clinthera.2011.10.027

U.S. Food and Drug Administration. (2025). Ziprasidone hydrochloride prescribing information. U.S. Department of Health and Human Services. FDA Ziprasidone Prescribing Information

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

06/10/2026

𝐓𝐫𝐢𝐯𝐢𝐚 𝐓𝐮𝐞𝐬𝐝𝐚𝐲!💊

𝐅𝐮𝐥𝐯𝐞𝐬𝐭𝐫𝐚𝐧𝐭 is a hormonal anticancer medication used mainly for the treatment of hormone receptor-positive breast cancer. It belongs to a class of medicines called selective estrogen receptor degraders (SERDs) and is administered through an intramuscular injection.

𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦 𝐨𝐟 𝐀𝐜𝐭𝐢𝐨𝐧
Fulvestrant binds to estrogen receptors and prevents estrogen from activating them. It also promotes the degradation of estrogen receptors, reducing estrogen-dependent signaling that can contribute to the growth of breast cancer cells.

𝐖𝐡𝐚𝐭 𝐢𝐬 𝐅𝐮𝐥𝐯𝐞𝐬𝐭𝐫𝐚𝐧𝐭 𝐮𝐬𝐞𝐝 𝐟𝐨𝐫?
Fulvestrant is used for the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. Depending on the patient's condition, it may be used alone or together with other anticancer medications.

𝐂𝐨𝐦𝐦𝐨𝐧 𝐒𝐢𝐝𝐞 𝐄𝐟𝐟𝐞𝐜𝐭𝐬
Some commonly reported side effects include injection-site pain, joint and muscle pain, back pain, nausea, fatigue, headache, hot flashes, decreased appetite, and gastrointestinal symptoms such as diarrhea or constipation.

𝐒𝐚𝐟𝐞𝐭𝐲 𝐑𝐞𝐦𝐢𝐧𝐝𝐞𝐫
Fulvestrant should be administered by a healthcare professional according to the prescribed treatment schedule. Patients should inform their healthcare provider about any liver problems, bleeding disorders, or use of blood-thinning medications. Report unusual bleeding, severe allergic reactions, or other concerning symptoms promptly.
Reference:

Fulvestrant. (n.d.). Go.Drugbank.Com. Retrieved October 5, 2026, from https://go.drugbank.com/drugs/DB00947

Fulvestrant. (2020). Mims.Com. https://www.mims.com/philippines/drug/info/fulvestrant?mtype=generic

Fulvestrant injection. (2026, February 27). Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/18313-fulvestrant-injection

Fulvestrant (intramuscular route) description and brand names - mayo clinic. (n.d.). Www.Mayoclinic.Org. Retrieved October 5, 2026, from https://www.mayoclinic.org/drugs-supplements/fulvestrant-intramuscular-route/description/drg-20063966

Robertson, J. F. R., & Harrison, M. (2004). Fulvestrant: Pharmacokinetics and pharmacology. British Journal of Cancer, 90(Suppl 1), S7–S10. https://doi.org/10.1038/sj.bjc.6601630

Image from:
PubChem. (n.d.-c). Fulvestrant. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Fulvestrant

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

02/10/2026

𝐗𝐏𝐑𝐓 𝐀𝐍𝐀𝐋𝐘𝐓𝐈𝐂𝐀𝐋 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧 stands with the global community in raising awareness about breast cancer, promoting early detection, and advocating for accessible and quality cancer care. This Breast Cancer Awareness Month, we recognize the importance of education, prevention, timely diagnosis, and continued support for individuals and families affected by breast cancer.

𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 remains one of the most common cancers affecting women worldwide. According to the 𝐖𝐨𝐫𝐥𝐝 𝐇𝐞𝐚𝐥𝐭𝐡 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧 (WHO), approximately 2.4 million women were diagnosed with breast cancer and 694,000 died from the disease globally in 2024. Early detection, timely diagnosis, and access to appropriate treatment play essential roles in improving breast cancer outcomes. By understanding the signs and symptoms, seeking medical advice when unusual changes occur, and encouraging regular consultations with healthcare professionals, we can help promote awareness and support those affected by this disease.

The 2026 message, “𝑬𝒗𝒆𝒓𝒚 𝑺𝒕𝒐𝒓𝒚 𝑰𝒔 𝑼𝒏𝒊𝒒𝒖𝒆, 𝑬𝒗𝒆𝒓𝒚 𝑱𝒐𝒖𝒓𝒏𝒆𝒚 𝑴𝒂𝒕𝒕𝒆𝒓𝒔,” emphasizes that every individual affected by breast cancer deserves understanding, compassion, and quality healthcare. It reminds us that behind every diagnosis is a personal story and a journey that deserves support. The WHO also highlights the importance of reducing inequalities in breast cancer care by strengthening early detection, ensuring timely diagnosis, and providing comprehensive treatment. No one should face breast cancer alone, and everyone deserves an equal opportunity to receive the care they need.

𝐋𝐞𝐭’𝐬 𝐫𝐚𝐢𝐬𝐞 𝐚𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬. 𝐄𝐧𝐜𝐨𝐮𝐫𝐚𝐠𝐞 𝐞𝐚𝐫𝐥𝐲 𝐝𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧. 𝐒𝐭𝐚𝐧𝐝 𝐭𝐨𝐠𝐞𝐭𝐡𝐞𝐫. 💗
Together, we can build a community that promotes awareness, supports every journey, and advocates for accessible and quality healthcare.
𝑬𝒗𝒆𝒓𝒚 𝒔𝒕𝒐𝒓𝒚 𝒎𝒂𝒕𝒕𝒆𝒓𝒔. 𝑬𝒗𝒆𝒓𝒚 𝒋𝒐𝒖𝒓𝒏𝒆𝒚 𝒎𝒂𝒕𝒕𝒆𝒓𝒔. 𝑬𝒗𝒆𝒓𝒚 𝒍𝒊𝒇𝒆 𝒎𝒂𝒕𝒕𝒆𝒓𝒔.
For breast health concerns or unusual changes, do not hesitate to consult a qualified healthcare professional. Early medical evaluation can make a difference.

𝐑𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞𝐬:
World Health Organization. (2026, July 3). Breast cancer. https://www.who.int/news-room/fact-sheets/detail/breast-cancer
World Health Organization. (2026, October 1). Breast Cancer Awareness Month 2026. https://www.who.int/news-room/events/detail/2026/10/01/default-calendar/breast-cancer-awareness-month-2026
World Health Organization. (n.d.). The Global Breast Cancer Initiative. https://www.who.int/initiatives/global-breast-cancer-initiative

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater to the cosmetic, veterinary, and other industries alike.

If you need more information about our services or have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

XPRT ANALYTICAL SERVICES Corporation

23/10/2026

20/10/2026

16/10/2026

13/10/2026

10/10/2026

09/10/2026

06/10/2026

02/10/2026

Address

Opening Hours

Telephone

Website

Alerts

Contact The Practice

Shortcuts

Share

Listing takedown request

Monday	7am - 3pm
Tuesday	7am - 3pm
Wednesday	7am - 3pm
Thursday	7am - 3pm
Friday	7am - 3pm